… ) gene has been thought to have an important role in the differential response to β 2 -agonist
therapy for asthma… However, previous studies have shown little evidence for an association …

… Severe asthma patients require treatment with high dose of inhaled … Short-acting
bronchodilators were withheld 6 h prior to … Genetic polymorphisms of the beta-2 andrenergic …

… In this study, the acute bronchodilator response in 121 … the clinical response to repetitive
administration of short-acting … The phosphodiesterase (PDE) 4D subfamily is thought to be the …

… sclerosis (SSc)-associated ILD and other chronic fibrosing … stroke [30] and response to
short-acting bronchodilators [31]. … -induced late-asthmatic response and reduced biomarkers of …

… PDE4A, 4B, 4C, and 4D mRNA subtypes are present in human … genetic variations and β
agonists among asthma patients by … , showed significant associations with responsiveness of β2 …

… Additionally, we show that Iso (a short-acting β 2 AR agonist), … study of pediatric patients
with asthma found that the children … Here we sought to examine responses to bronchodilators …

… of genetic polymorphisms and adipokines effects in children … pathway, which further
responds by releasing anorexigenic … were not associated with asthma in children (Citation21). …

… beta-2 adrenergic agonists are administered for the acute relief … beta-2 agonists for asthmatic
patients that are poorly controlled … of more potent bronchodilators such as short-acting beta-…

… selective PDE inhibitors in the treatment of COPD and asthma. … relies mainly on the use of
bronchodilators (β 2 -adrenoceptor (… the role of PDE3 in an acute house dust mite-driven (HDM-…

… 17q21 strongly associated with childhood-onset asthma. Variation … to repetitive or continuous
administration of short-acting … evaluating levalbuterol and albuterol for acute asthma in all …